Bausch Health’s Strategic Growth in Latin...

By HEOR Staff Writer

January 8, 2026

Navigating Growth in Latin American Pharmaceuticals In the Latin American pharmaceuticals sector, Bausch Health is strategically expanding its footprint under the leadership of Vic...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Weight Loss: Advances in Hormone-Based Obesity Treatments
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Obesity Health Economics: Forecasting Trends and Costs in the US
Evolving Burden of Obesity in the US: Key Insights on Obesity Prevention Stra...
Insights on GLP-1 Therapy in Bariatric Surgery Patients
Impact of Generic Liraglutide Launch on Weight Management and Health Economics
Mounjaro Price Increase UK: Impacts on Access and Health Economics
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
NICE’s 2025 Guidance on Obesity Management Support
Caution Advised: Conflicts in AAP Childhood Obesity Guidelines
Business Dynamics: How Novo Nordisk Lost GLP-1 Market Share